Kaempferol ameliorates symptoms of metabolic syndrome by regulating activities of liver X receptor-β

Minh Hien Hoang, Yaoyao Jia, Boram Mok, Hee jin Jun, Kwang Yeon Hwang, Sung Joon Lee

Research output: Contribution to journalArticlepeer-review

42 Citations (Scopus)


Kaempferol is a dietary flavonol previously shown to regulate cellular lipid and glucose metabolism. However, its molecular mechanisms of action and target proteins have remained elusive, probably due to the involvement of multiple proteins. This study investigated the molecular targets of kaempferol. Ligand binding of kaempferol to liver X receptors (LXRs) was quantified by time-resolved fluorescence resonance energy transfer and surface plasmon resonance analyses. Kaempferol directly binds to and induces the transactivation of LXRs, with stronger specificity for the β-subtype (EC50=0.33μM). The oral administration of kaempferol in apolipoprotein-E-deficient mice (150mg/day/kg body weight) significantly reduced plasma glucose and increased high-density lipoprotein cholesterol levels and insulin sensitivity compared with the vehicle-fed control. Kaempferol also reduced plasma triglyceride concentrations and did not cause liver steatosis, a common side effect of potent LXR activation. In immunoblotting analysis, kaempferol reduced the nuclear accumulation of sterol regulatory element-binding protein-1 (SREBP-1). Our results show that the suppression of SREBP-1 activity and the selectivity for LXR-β over LXR-α by kaempferol contribute to the reductions of plasma and hepatic triglyceride concentrations in mice fed kaempferol. They also suggest that kaempferol activates LXR-β and suppresses SREBP-1 to enhance symptoms in metabolic syndrome.

Original languageEnglish
Pages (from-to)868-875
Number of pages8
JournalJournal of Nutritional Biochemistry
Issue number8
Publication statusPublished - 2015 Aug 1

Bibliographical note

Funding Information:
We thank the Korea Basic Science Institute for providing the Biacore instrument to perform the SPR analysis. This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) ( 2013R1A2A2A01016176 ).

Publisher Copyright:
© 2015 Elsevier Inc.


  • Kaempferol
  • Lipid metabolism
  • Liver X receptor
  • Metabolic syndrome
  • Peroxisome proliferation-activated receptor
  • Sterol regulatory element-binding protein-1c

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Biology
  • Nutrition and Dietetics
  • Clinical Biochemistry


Dive into the research topics of 'Kaempferol ameliorates symptoms of metabolic syndrome by regulating activities of liver X receptor-β'. Together they form a unique fingerprint.

Cite this